Selexipag

CHEMBL238804 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

496.6 g/mol

LogP

3.8

Phase

4

Taken orally twice daily, this medication mimics the action of a natural substance called prostacyclin to relax and widen the blood vessels in the lungs, reducing the pressure that the heart must work against. It helps slow the progression of pulmonary arterial hypertension and lowers the risk of disease worsening requiring hospitalization.

분자량

496.6000 g/mol

LogP

3.80

TPSA

110.00 Å²

리핀스키 5의 법칙

통과

치료 영역

Hypertension

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1

InChI

InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)

Molecular Formula

C26H32N4O4S

HBD / HBA

1 / 7

회전 가능 결합

12

무거운 원자

35

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Taken orally twice daily, this medication mimics the action of a natural substance called prostacyclin to relax and widen the blood vessels in the lungs, reducing the pressure that the heart must work against. It helps slow the progression of pulmonary arterial hypertension and lowers the risk of disease worsening requiring hospitalization.

Yes, Selexipag is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL238804. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 9913767. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Selexipag PillFYI에서

구조

핵심 데이터

분자식: C26H32N4O4S
동의어: 1

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.